LowSalt4Life: A Mobile Application to Reduce Sodium Intake And Blood Pressure
NCT ID: NCT05396001
Last Updated: 2025-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
410 participants
INTERVENTIONAL
2022-08-15
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tailored Messaging to Reduce Sodium Intake
NCT03099343
Improving Blood Pressure Control Through the myBPmyLife mHealth Application
NCT05154929
MOBILE Intervention in College Students With Elevated Blood Pressure
NCT05956925
Impact of Self-monitoring of Salt Intake by Salt Meter in Hypertensive Patients
NCT04286802
Sodium Healthy Living Project
NCT03027791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During the first 2 months of the study, a micro-randomized trial (MRT) will be performed within the App+JITAI group (N=200). This MRT is designed to learn which push notification messages effectively prompt the user to interact with the appropriate content within the mobile application.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LowSalt4Life
LowSalt4Life Application
LowSalt4Life is a dietary sodium intervention mobile application that promotes lower sodium intake.
LowSalt4Life + just-in-time adaptive intervention (JITAI)
LowSalt4Life Application
LowSalt4Life is a dietary sodium intervention mobile application that promotes lower sodium intake.
Just-In-time Adaptive Intervention (JITAI)
LowSalt4Life is a dietary sodium application with a just-in-time adaptive intervention (JITAI) component enabled.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LowSalt4Life Application
LowSalt4Life is a dietary sodium intervention mobile application that promotes lower sodium intake.
Just-In-time Adaptive Intervention (JITAI)
LowSalt4Life is a dietary sodium application with a just-in-time adaptive intervention (JITAI) component enabled.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. A smartphone with a compatible Apple or Android operating system installed and able to download and use LowSalt4Life app including accepting all permissions and willing to allow the mobile applications to send push notifications
3. A valid email address
4. Fluent in spoken and written English
Exclusion Criteria
2. Contraindication to a sodium restriction diet
3. An estimated sodium intake less than 1,500mg per day
4. Known secondary causes of HTN (e.g., adrenal insufficiency, pheochromocytoma)
5. Estimated glomerular filtration rate (EGFR) \<30 or end-stage renal disease on dialysis
6. Heart failure
7. Inability to use Withings devices (blood pressure cuff and scale) due to equipment limitations or contraindications
8. Currently pregnant or intent to become pregnant during the study period
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brahmajee K Nallamothu
Stevo Julius Research Professor of Cardiovascular Medicine and Professor of Internal Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brahmajee Nallamothu
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00210954
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.